Doha: Researchers at Qatar University (QU) and Weill Cornell Medicine-Qatar (WCM-Q) have described an intriguing and rapid evolution of the herpes simplex virus type-1 (HSV-1) epidemic in the United States (US), with less infection in childhood but more in adulthood, and less oral infection but more genital infection.

HSV-1 is a highly contagious virus and one of the most widespread infections globally. It is normally transmitted orally during childhood, leading to blisters and lesions around the mouth known as oral herpes. Recent data from several countries, however, showed that HSV-1 can also be transmitted sexually, through various sexual practices, leading to genital herpes and genital ulcer disease.

The QU and WCM-Q study, published in the prestigious journal BMC Medicine, developed a sophisticated mathematical model to quantitatively characterize the level and trend of the HSV-1 epidemic in the US. The study indicated that HSV-1 infection is undergoing a more subtle transition than previously thought, with this infection propagating through four different modes of transmission in the population, and affecting different age cohorts in different ways. Oral-genital contact, in particular, was found to be playing an important role in infection transmission for young adults, with 25% of infections among them being genital and leading to genital herpes.

The study estimated that there are 3 million new HSV-1 infections every year, a level that will persist for several decades. Of this total, close to 500,000 will be genital infections, mainly through oral-genital contact. HSV-1 will persist as a major cause of first-episode genital herpes among youth in the US for decades to come, surpassing the contribution of that of HSV-2, a related infection transmitted mainly through sexual intercourse. HSV-2 has been historically the main cause of genital herpes until present times.

Despite these increasing rates of genital herpes, the study indicated steep declines in oral herpes in children. The study also predicted that the fraction of the population who will carry the infection will decline with time, and this decline will be most pronounced by 2050.

“It was striking for us to see this major shift in HSV-1 transmission patterns, and how this infection is affecting different age groups very differently. While oral herpes is declining rapidly for children, genital herpes is increasing steadily for young adults,” said Dr. Houssein Ayoub, lead author of the study and assistant professor in the Department of Mathematics, Statistics, and Physics at QU.

Hiam Chemaitelly, second author of the study and senior epidemiologist at WCM-Q added: “The increase in genital herpes due to oral-genital contact is of particular concern, as this is affecting young adults, mainly women, who have to endure significant psychosocial and sexual consequences once they discover these genital blisters, often shortly after their sexual debut.”

Dr. Laith Abu-Raddad, principal investigator of the study and professor of healthcare policy and research at WCM-Q, concluded: “These findings demonstrate the criticality of accelerating HSV-1 vaccine development to control transmission and to prevent the medical and psychosocial disease burden that is emerging from this infection.”

The study, ‘Characterizing the Transitioning Epidemiology of Herpes Simplex Virus Type 1 in the United States: Model-Based Predictions’, was conducted through a collaboration between QU and WCM-Q with funding from the Qatar National Research Fund, a Qatar Foundation member, through the National Priorities Research Program (NPRP 9-040-3-008).

Key scientific findings of the study

  • HSV-1 infection in the US is transitioning from being an oral infection typically acquired during childhood, to increasingly a sexually transmitted infection and a major cause of first-episode genital herpes among young adults.
  • The number of new HSV-1 infections will persist at 3 million new infections every year. Of this total, close to half a million will be genital infections, mainly through oral-genital contact and leading to genital herpes.
  • Young adults, and specially women, will be most affected with 25% of new cases among them being genital infections.

 -Ends-

About Weill Cornell Medicine - Qatar:
Weill Cornell Medicine - Qatar (WCM-Q) is a partnership between Cornell University and Qatar Foundation. It offers pre-medical and medical courses leading to the Cornell University M.D. degree with teaching by Cornell and Weill Cornell faculty and by physicians at Hamad Medical Corporation (HMC) and Aspetar Orthopedic and Sports Medicine Hospital who hold Weill Cornell appointments. Through its biomedical research program, WCM-Q is building a sustainable research community in Qatar while advancing basic science and clinical research. Through its medical college, WCM-Q seeks to provide the finest education possible for medical students, to improve health care both now and for future generations, and to provide high quality health care to the Qatari population.

About Qatar University                        
Qatar University is one of the leading institutions of academic and research excellence in the GCC region. It provides high quality undergraduate and graduate programs that prepare competent graduates, primed to shape the future of Qatar.  The organization's strong relationship with Qatari society is reflected in its community service efforts and in its vibrant research portfolio that addresses relevant local and regional challenges, advances national goals towards a knowledge-based economy, and contributes actively to the needs and aspirations of the society.

www.qu.edu.qa  

For more info, please contact:
Hanan Lakkis
Associate Director, Media
Weill Cornell Medicine - Qatar
Mobile: +974 55536564
Direct Line: +974 44928661
hyl2004@qatar-med.cornell.edu 

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.